Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia

S Alkindi1, R A Elsadek2, A Al-Madhani3

  • 1Department of Haematology, Sultan Qaboos University Hospital, Oman; College of Medicine and Health Sciences, Muscat, Oman.

Insights

COVID-19 may trigger vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients, but did not significantly increase VOC-related morbidity or mortality in this cohort.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Public Health

Background:

  • Sickle cell anaemia (SCA) is a genetic blood disorder characterized by abnormal haemoglobin, leading to vasooclusive crises (VOCs).
  • The impact of COVID-19 on SCA patients, particularly concerning VOCs, requires thorough investigation due to potential synergistic effects on morbidity and mortality.

Purpose of the Study:

  • To evaluate the effect of COVID-19 infection on the frequency and severity of vasooclusive crises (VOCs) in patients with sickle cell anaemia (SCA).
  • To assess the influence of COVID-19 on the morbidity and mortality associated with VOCs in SCA patients.

Main Methods:

  • A prospective cohort study involving 100 SCA patients, divided into two groups: 50 with confirmed COVID-19 (COVID group) and 50 without (non-COVID group).
  • Data collection included VOC episodes, hospitalizations, specific clinical manifestations, laboratory markers (hemoglobin, white blood cell count, platelets, lactate dehydrogenase, ferritin), and mortality rates.

Main Results:

  • The COVID group experienced a higher median number of VOC episodes annually (3 vs 2, P < 0.05) and presented with more specific complications like osteonecrosis, splenic sequestration, splenomegaly, and hepatic crisis.
  • While both groups showed reduced mean hemoglobin and lymphocyte subsets, the COVID group exhibited a subdued rise in white blood cell count, reticulocyte percentage, platelets, and ferritin.
  • Hospitalization rates were similar between groups, and there was no statistically significant difference in mortality (2 deaths in the COVID group vs 3 in the non-COVID group).

Conclusions:

  • COVID-19 infection may act as a trigger for vasooclusive crises (VOCs) in individuals with sickle cell anaemia (SCA).
  • Despite increased VOC episodes and certain complications, COVID-19 did not significantly elevate overall VOC-related morbidity or mortality within this SCA cohort.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
120
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
120
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K